Vanloese, Denmark

Søren Kjærulff

This inventor holds 2 USPTO granted patents. Top assignees: Novo Nordisk A/s, Novozymes A/s. Active years: 2001-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Søren Kjærulff. Retrieved from https://idiyas.com/inventor/sandoslashren-kjandaeligrulff

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 76(Granted Patents)


Company Filing History:


Years Active: 2001-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Søren Kjærulff: Innovator in Enzyme Technology

Introduction

Søren Kjærulff is a notable inventor based in Vanløse, Denmark. He has made significant contributions to the field of enzyme technology, particularly through his work on α-amylase mutants. With a total of 2 patents, his innovations have the potential to enhance various industrial applications.

Latest Patents

Søren's latest patents focus on variants of a parent Termamyl-like α-amylase. The first patent describes a variant that exhibits improved pH stability at a pH range from 8 to 10.5, enhanced calcium stability at the same pH range, and increased specific activity at temperatures between 10 to 60°C. The second patent similarly addresses a variant of the α-amylase with the same improvements in stability and activity, showcasing his dedication to advancing enzyme performance.

Career Highlights

Throughout his career, Søren has worked with prominent companies in the biotechnology sector, including Novo Nordisk A/S and Novozymes A/S. His experience in these organizations has allowed him to develop and refine his innovative ideas in enzyme technology.

Collaborations

Søren has collaborated with esteemed colleagues such as Carsten Schau Andersen and Allan Svendsen. These partnerships have likely contributed to the success of his inventions and the advancement of enzyme research.

Conclusion

Søren Kjærulff's work in enzyme technology exemplifies the impact of innovation in the biotechnology field. His patents on α-amylase mutants highlight his commitment to improving industrial processes through scientific advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…